Insulin Analogs intermediate
Insulin Degludec Aspart Combination
Dual insulin formulation combining degludec and aspart in fixed ratio for diabetes. This peptide or oligopeptide is studied for its biological activity, stru...
By Encyclopeptide Editorial | 1 min read
Insulin diabetes peptide
Chemical Identity
| Property | Value |
|---|---|
| Peptide Class | Insulin Analogs |
| Route | Various |
Structure
Insulin Degludec Aspart Combination is a biologically active peptide with well-characterized structural properties relevant to its mechanism of action.
Mechanism of Action
Dual insulin formulation combining degludec and aspart in fixed ratio for diabetes.
Clinical Applications
- Primary indication: Therapeutic application based on receptor binding and signaling
- Secondary applications: Related therapeutic uses under investigation
Pharmacokinetics
- Half-life: Variable by formulation
- Route: SC, IV, or oral depending on formulation
- Metabolism: Proteolytic degradation
Safety and Side Effects
Adverse effects vary by specific peptide and indication. Monitoring recommended during therapy.
References
- Primary literature for Insulin Degludec Aspart Combination
- Clinical trial data and pharmacological studies
Test Your Knowledge
Reinforce what you learned about Insulin Degludec Aspart Combination with interactive quizzes on Wikipept.
Take a Quiz on Wikipept